These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31981686)

  • 21. A critical evaluation of the fish early-life stage toxicity test for engineered nanomaterials: experimental modifications and recommendations.
    Shaw BJ; Liddle CC; Windeatt KM; Handy RD
    Arch Toxicol; 2016 Sep; 90(9):2077-2107. PubMed ID: 27318802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving Control of Occupational Exposures to Engineered Nanomaterials.
    Juric A; Meldrum R; Liberda EN
    J Occup Environ Hyg; 2015; 12(8):501-8. PubMed ID: 25635953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difficulties in establishing regulations for engineered nanomaterials and considerations for policy makers: avoiding an unbalance between benefits and risks.
    Garduño-Balderas LG; Urrutia-Ortega IM; Medina-Reyes EI; Chirino YI
    J Appl Toxicol; 2015 Oct; 35(10):1073-85. PubMed ID: 26046543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occupational Exposures to Engineered Nanomaterials: a Review of Workplace Exposure Assessment Methods.
    McCormick S; Niang M; Dahm MM
    Curr Environ Health Rep; 2021 Sep; 8(3):223-234. PubMed ID: 34101152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic Review of Screening and Surveillance Programs to Protect Workers from Nanomaterials.
    Gulumian M; Verbeek J; Andraos C; Sanabria N; de Jager P
    PLoS One; 2016; 11(11):e0166071. PubMed ID: 27829014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Literature Review of (Q)SAR Modelling of Nanomaterial Toxicity.
    Oksel C; Ma CY; Liu JJ; Wilkins T; Wang XZ
    Adv Exp Med Biol; 2017; 947():103-142. PubMed ID: 28168667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point of departure (PoD) selection for the derivation of acceptable daily exposures (ADEs) for active pharmaceutical ingredients (APIs).
    Bercu JP; Morinello EJ; Sehner C; Shipp BK; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S48-56. PubMed ID: 27233925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Systematic Review of Reported Exposure to Engineered Nanomaterials.
    Debia M; Bakhiyi B; Ostiguy C; Verbeek JH; Brouwer DH; Murashov V
    Ann Occup Hyg; 2016 Oct; 60(8):916-35. PubMed ID: 27422281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Workplace practices for engineered nanomaterial manufacturers.
    Woskie S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(6):685-92. PubMed ID: 20593453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms involved in the impact of engineered nanomaterials on the joint toxicity with environmental pollutants.
    Liu Y; Nie Y; Wang J; Wang J; Wang X; Chen S; Zhao G; Wu L; Xu A
    Ecotoxicol Environ Saf; 2018 Oct; 162():92-102. PubMed ID: 29990744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sharpening the focus on occupational safety and health in nanotechnology.
    Schulte P; Geraci C; Zumwalde R; Hoover M; Castranova V; Kuempel E; Murashov V; Vainio H; Savolainen K
    Scand J Work Environ Health; 2008 Dec; 34(6):471-8. PubMed ID: 19137209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Systematic Review of the Routes and Forms of Exposure to Engineered Nanomaterials.
    Basinas I; Jiménez AS; Galea KS; Tongeren MV; Hurley F
    Ann Work Expo Health; 2018 Jul; 62(6):639-662. PubMed ID: 29931230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposures during wet production and use processes of nanomaterials: a summary of 11 worksite evaluations.
    Glassford E; Neu-Baker NM; Dunn KL; Dunn KH
    Ind Health; 2020 Oct; 58(5):467-478. PubMed ID: 32321887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of REACH-derived no-effect levels for workers with EU indicative occupational exposure limit values and national limit values in Finland.
    Tynkkynen S; Santonen T; Stockmann-Juvala H
    Ann Occup Hyg; 2015 May; 59(4):401-15. PubMed ID: 25638729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical aspects in occupational exposure assessment with different aerosol metrics in an industrial spray coating process.
    Belosi F; Koivisto AJ; Furxhi I; de Ipiña JL; Nicosia A; Ravegnani F; Ortelli S; Zanoni I; Costa A
    NanoImpact; 2023 Apr; 30():100459. PubMed ID: 36948454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Environmental risk assessment of engineered nano-SiO
    Wang Y; Nowack B
    Environ Toxicol Chem; 2018 May; 37(5):1387-1395. PubMed ID: 29315795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental behaviors and toxic mechanisms of engineered nanomaterials in soil.
    Wang C; Chen L; Xu J; Zhang L; Yang X; Zhang X; Zhang C; Gao P; Zhu L
    Environ Res; 2024 Feb; 242():117820. PubMed ID: 38048867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Workplace exposure to engineered nanomaterials: the Italian path for the definition of occupational health and safety policies.
    Mirabile M; Boccuni F; Gagliardi D; Rondinone BM; Iavicoli S
    Health Policy; 2014 Jul; 117(1):128-34. PubMed ID: 24582490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility Factors in Chronic Lung Inflammatory Responses to Engineered Nanomaterials.
    You DJ; Bonner JC
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33022979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.